One of the major scientific challenges in vaccinology today is the development of an effective AIDS vaccine Evidence has been accumulated that MHC class I restricted CD8+ cytotoxic T lymphocyte (CTL) responses may provide protection against HIV infection. As Phase I/II clinical trials for testing of candidate AIDS vaccines progresses, canarypox-based vaccine strategies have elicited anti-HIV-1 CTL in a significant number of uninfected immunized volunteers. Although we have begun to better understand the specificity and duration of the elicited CTL reactivities, little is still known about the qualitative aspects of these responses. Based on preliminary studies performed in association with recently completed trials, the specific aims of this proposal are designed to test the major hypothesis that vaccine induced anti-HIV CTL responses are qualitatively different from the responses elicited by natural HIV infection. Studies are designed to characterize CTL lines, and ultimately CTL clones, from antigen-specific in vitro stimulation (IVS) cultures with respect to avidity, TcR receptor breadth, as well as cytolytic and non-cytolytic virus suppressive reactivities against autologous lymphocyte target cells infected with primary isolates representing genetically diverse viral clades. Avidity will be measured both by conventional peptide titration as well as peptide/MHC tetramer binding. Tetramers will also be utilized to track epitope-specific CTL and their maturation stage in PBMC from vaccinees. The capacity of canarypox vectors to bias the CTL responses of vaccinees will also be studied at the level of in vitro CTLp amplification, using a panel of different HIV-expressing recombinant vectors in different APC-based antigen-specific stimulation strategies as well as HIV-1-specific activation. Lastly, comparative studies will be performed to determine whether the quality of vaccine- induced CTL reactivities more closely resemble CTL responses that develop during the acute phase of HIV-1 infection, especially in association with structured early treatment interruption before the immune depletion associated with prolonged viral stimulation and infection become manifest. By yielding new insights into the quality of vaccine-induced CTL, these studies could greatly impact the further development of vector-based vaccines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI050483-01
Application #
6409087
Study Section
Special Emphasis Panel (ZRG1-VACC (01))
Program Officer
Pensiero, Michael N
Project Start
2001-09-01
Project End
2005-06-30
Budget Start
2001-09-01
Budget End
2002-06-30
Support Year
1
Fiscal Year
2001
Total Cost
$311,850
Indirect Cost
Name
Duke University
Department
Surgery
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Gay, Cynthia L; Willis, Sarah J; Cope, Anna B et al. (2016) Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability. AIDS 30:2815-2822
Vinikoor, Michael J; Cope, Anna; Gay, Cynthia L et al. (2013) Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation. J Acquir Immune Defic Syndr 62:505-8
Frahm, Marc A; Picking, Ralph A; Kuruc, JoAnn D et al. (2012) CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection. J Immunol 188:4289-96
Arnoczy, Gretchen S; Ferrari, Guido; Goonetilleke, Nilu et al. (2012) Massive CD8 T cell response to primary HIV infection in the setting of severe clinical presentation. AIDS Res Hum Retroviruses 28:789-92
Ferrari, Guido; Korber, Bette; Goonetilleke, Nilu et al. (2011) Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection. PLoS Pathog 7:e1001273
Ferrari, Guido; Pollara, Justin; Kozink, Daniel et al. (2011) An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum. J Virol 85:7029-36
Frahm, Marc; Goswami, Neela D; Owzar, Kouros et al. (2011) Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis (Edinb) 91:250-6
Pollara, Justin; Hart, Lydia; Brewer, Faraha et al. (2011) High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses. Cytometry A 79:603-12
Makedonas, George; Hutnick, Natalie; Haney, Danielle et al. (2010) Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. PLoS Pathog 6:e1000798
Lambotte, Olivier; Ferrari, Guido; Moog, Christiane et al. (2009) Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS 23:897-906

Showing the most recent 10 out of 14 publications